Krüppel-like factor 2(KLF2),a potential target for neuroregenerationSurajit Hansda,Prateeksha Prateeksha,Hiranmoy Das2327-2328
Defined hydrogels for spinal cord organoids:challenges and potential applicationsWai Hon Chooi,Yuewen Wu,Shi-Yan Ng2329-2330
Neuronal trafficking as a key to functional recovery in immune-mediated neuropathiesFelix Kohle,Michael Schroeter2331-2332
Advancements in personalized stem cell models for aging-related neurodegenerative disordersMingxi Weng,Ralf Jauch2333-2334
New insights into astrocyte diversity from the lens of transcriptional regulation and their implications for neurodegenerative disease treatmentsIbrahim Olabayode Saliu,Guoyan Zhao2335-2336
Harnessing endothelial cells and vascularization strategies for nerve regenerationPapon Muangsanit,Poppy Smith2337-2338
Unraveling the potential of acute intermittent hypoxia as a strategy for inducing robust repair in multiple sclerosisValerie M.K.Verge,Nataliya Tokarska,Justin M.Naniong2339-2340
Next-generation regenerative therapy for ischemic stroke using peripheral blood mononuclear cellsMasato Kanazawa,Itaru Ninomiya,Yutaka Otsu,Masahiro Hatakeyama2341-2342